Advertisement

Diabetes and Sleep Disorders

  • Shalinee Chawla
  • Steve H. SalzmanEmail author
Reference work entry

Abstract

Although the prevalence of both diabetes and sleep apnea coincides with the epidemic of obesity, current evidence suggests that the interconnections between diabetes and obstructive sleep apnea–hypopnea syndrome (OSA) are not simply due to their common risk factor of obesity. Physiologic derangements and mediators released during sleep as a result of OSA appear to lead to impaired glucose metabolism, increasing the likelihood of diabetes and impairing the efficacy of its treatment. In addition, the metabolic abnormalities of diabetes could worsen the severity of OSA or affect compensatory mechanisms.

Keywords

Obstructive sleep apnea Sleep disordered breathing AHI apnea hypopnea index 

Notes

Acknowledgments

This revision to Diabetes and Sleep Disorders would not have been possible if not for the excellent initial chapter authored by Drs. Abhijith Hegde and Steve H. Salzman.

References

  1. 1.
    Hla KM, Young TB, Bidwell T, et al. Sleep apnea and hypertension. A population-based study. Ann Intern Med. 1994;120:382–8.CrossRefPubMedGoogle Scholar
  2. 2.
    Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000;320:479–82.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829–36.CrossRefPubMedGoogle Scholar
  4. 4.
    Young T, Peppard P, Palta M, et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med. 1997;157:1746–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Grote L, Ploch T, Heitmann J, et al. Sleep-related breathing disorder is an independent risk factor for systemic hypertension. Am J Respir Crit Care Med. 1999;160:1875–82.CrossRefPubMedGoogle Scholar
  6. 6.
    Bixler EO, Vgontzas AN, Lin HM, et al. Association of hypertension and sleep-disordered breathing. Arch Intern Med. 2000;160:2289–95.CrossRefPubMedGoogle Scholar
  7. 7.
    Bradley TD, Rutherford R, Grossman RF, et al. Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis. 1985;131:835–9.PubMedGoogle Scholar
  8. 8.
    Sajkov D, Cowie RJ, Thornton AT, et al. Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1994;149:416–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Guidry UC, Mendes LA, Evans JC, et al. Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am J Respir Crit Care Med. 2001;164:933–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al. Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J. 2006;27:1106–13.CrossRefPubMedGoogle Scholar
  11. 11.
    Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet. 2005;365:1046–53.CrossRefPubMedGoogle Scholar
  12. 12.
    Peker Y, Carlson J, Hedner J. Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 2006;28:596–602.CrossRefPubMedGoogle Scholar
  13. 13.
    Yumino D, Tsurumi Y, Takagi A, et al. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol. 2007;99:26–30.CrossRefPubMedGoogle Scholar
  14. 14.
    Gami AS, Rader S, Svatikova A, et al. Familial premature coronary artery disease mortality and obstructive sleep apnea. Chest. 2007;131:118–21.CrossRefPubMedGoogle Scholar
  15. 15.
    Arzt M, Young T, Finn L, et al. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172:1447–51.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Yaggi HK, Concato J, Kernan WN, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 2005;353:2034–41.CrossRefPubMedGoogle Scholar
  17. 17.
    Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep-disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–6.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Garrigue S, Pepin JL, Defaye P, et al. High prevalence of sleep apnea syndrome in patients with long-term pacing: the European Multicenter Polysomnographic Study. Circulation. 2007;115:1703–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Alonso-Fernandez A, Garcia-Rio F, Racionero MA, et al. Cardiac rhythm disturbances and ST-segment depression episodes in patients with obstructive sleep apnea-hypopnea syndrome and its mechanisms. Chest. 2005;127:15–22.CrossRefPubMedGoogle Scholar
  20. 20.
    Zwillich C, Devlin T, White D, et al. Bradycardia during sleep apnea. Characteristics and mechanism. J Clin Invest. 1982;69:1286–92.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Miller WP. Cardiac arrhythmias and conduction disturbances in the sleep apnea syndrome. Prevalence and significance. Am J Med. 1982;73:317–21.CrossRefPubMedGoogle Scholar
  22. 22.
    Tilkian AG, Guilleminault C, Schroeder JS, et al. Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med. 1977;63:348–58.CrossRefPubMedGoogle Scholar
  23. 23.
    Walsh J. Sleep disorders medicine. Rochester: Association of Professional Sleep Societies; 1986.Google Scholar
  24. 24.
    Holland JV, Dement WC, Raynal DM. Polysomnography: a response to a need for improved communication. In: Presented at the 14th annual meeting of the association for the psychophysiological study of sleep. Jackson Hole: Association for the psychophysiological study of sleep; 1974. p. 121.Google Scholar
  25. 25.
    Iber C, Ancoli-Israel S, Chesson AL, et al. The AASM manual for the scoring of sleep and associated events. West Chester: American Academy of Sleep Medicine; 2007.Google Scholar
  26. 26.
    Strohl KP, Redline S. Recognition of obstructive sleep apnea. Am J Respir Crit Care Med. 1996;154:279–89.CrossRefPubMedGoogle Scholar
  27. 27.
    Hiestand DM, Britz P, Goldman M, et al. Prevalence of symptoms and risk of sleep apnea in the US population: results from the national sleep foundation sleep in America 2005 poll. Chest. 2006;130:780–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Young T, Skatrud J, Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA. 2004;291:2013–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Palmer LJ, Redline S. Genomic approaches to understanding obstructive sleep apnea. Respir Physiol Neurobiol. 2003;135:187–205.CrossRefPubMedGoogle Scholar
  30. 30.
    Strohl KP, Cherniak NS, Gothe B. Physiologic basis of therapy for sleep apnea. Am Rev Respir Dis. 1986;134:791.PubMedGoogle Scholar
  31. 31.
    Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14:540–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Davies RJ, Stradling JR. The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnoea syndrome. Eur Respir J. 1990;3:509–14.PubMedGoogle Scholar
  33. 33.
    Browman CP, Sampson MG, Yolles SF, et al. Obstructive sleep apnea and body weight. Chest. 1984;85:435–8.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med. 1985;103:p850–5.CrossRefGoogle Scholar
  35. 35.
    Issa FG, Sullivan CE. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry. 1982;45:353–9.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Chervin RD, Theut S, Bassetti C, et al. Compliance with nasal CPAP can be improved by simple interventions. Sleep. 1997;20:284–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Pepin JL, Krieger J, Rodenstein D, et al. Effective compliance during the first 3 months of continuous positive airway pressure. A European prospective study of 121 patients. Am J Respir Crit Care Med. 1999;160:1124–9.CrossRefPubMedGoogle Scholar
  38. 38.
    Aloia MS, Di Dio L, Ilniczky N, et al. Improving compliance with nasal CPAP and vigilance in older adults with OAHS. Sleep Breath. 2001;5:13–21.CrossRefPubMedGoogle Scholar
  39. 39.
    He J, Kryger MH, Zorick FJ, et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest. 1988;94:9–14.CrossRefPubMedGoogle Scholar
  40. 40.
    Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez N, et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest. 2005;128:624–33.CrossRefPubMedGoogle Scholar
  41. 41.
    Bahammam A, Delaive K, Ronald J, et al. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep. 1999;22:740–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Kapur V, Blough DK, Sandblom RE, et al. The medical cost of undiagnosed sleep apnea. Sleep. 1999;22:749–55.CrossRefPubMedGoogle Scholar
  43. 43.
    Giles TL, Lasserson TJ, Smith BJ, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2006;25(1):CD001106.Google Scholar
  44. 44.
    Patel SR, White DP, Malhotra A, et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med. 2003;163:565–71.CrossRefPubMedGoogle Scholar
  45. 45.
    Gotsopoulos H, Chen C, Qian J, et al. Oral appliance therapy improves symptoms in obstructive sleep apnea: a randomized, controlled trial. Am J Respir Crit Care Med. 2002;166:743–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Hoekema A, Stegenga B, De Bont LG. Efficacy and co-morbidity of oral appliances in the treatment of obstructive sleep apnea-hypopnea: a systematic review. Crit Rev Oral Biol Med. 2004;15:137–55.CrossRefPubMedGoogle Scholar
  47. 47.
    Schwartz JR, Hirshkowitz M, Erman MK, et al. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea: a 12-week, open-label study. Chest. 2003;124:2192–9.CrossRefPubMedGoogle Scholar
  48. 48.
    Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. 2005;28:464–71.CrossRefPubMedGoogle Scholar
  49. 49.
    Hirshkowitz M, Black JE, Wesnes K, et al. Adjunct armodafinil improves wakefulness and memory in obstructive sleep apnea/hypopnea syndrome. Respir Med. 2007;101:616–27.CrossRefPubMedGoogle Scholar
  50. 50.
    Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: US Department of Health and Human Services; 2014.Google Scholar
  51. 51.
    West SD, Nicoll DJ, Stradling JR. Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax. 2006;61:945–50.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care. 2009;32:1017–9.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Spath-Schwalbe E, Gofferje M, Kern W, et al. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry. 1991;29:575–84.CrossRefPubMedGoogle Scholar
  54. 54.
    Semple PD, Beastall GH, Watson WS, et al. Hypothalamic-pituitary dysfunction in respiratory hypoxia. Thorax. 1981;36:605–9.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Raff H, Roarty TP. Renin, ACTH and aldosterone during acute hypercapnia and hypoxia in conscious rats. Am J Physiol. 1988;254:R431–5.PubMedGoogle Scholar
  56. 56.
    Raff H, Shinsako J, Keil LC, et al. Vasopressin, ACTH and corticosteroids during hypercapnia and graded hypoxia in dogs. Am J Physiol. 1983;244:E453–8.PubMedGoogle Scholar
  57. 57.
    Shin MK, Han W, Bevans –Fonti S, et al. The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia. Respir Physiol Neurobiol. 2014;203:60–7.CrossRefPubMedGoogle Scholar
  58. 58.
    Strohl KP, Novak RD, Singer W, et al. Insulin levels, blood pressure and sleep apnea. Sleep. 1994;17:614–8.CrossRefPubMedGoogle Scholar
  59. 59.
    Ip MS, Lam B, Ng MM, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med. 2002;165:670–6.CrossRefPubMedGoogle Scholar
  60. 60.
    Vgontzas A, Legro RS, Bixler EO, et al. Polycystic Ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab. 2001;86:517–20.PubMedGoogle Scholar
  61. 61.
    Vgontzas A, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab. 2000;85:1151–8.CrossRefPubMedGoogle Scholar
  62. 62.
    Punjabi NM, Sorkin JD, Katzel LI, et al. Sleep disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med. 2002;165:677–82.CrossRefPubMedGoogle Scholar
  63. 63.
    Saaresranta T, Polo O. Sleep-disordered breathing and hormones. Eur Respir J. 2003;22:161–72.CrossRefPubMedGoogle Scholar
  64. 64.
    Gotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87–91.CrossRefGoogle Scholar
  65. 65.
    DeCourten M, Zimmet P, Hodge A, et al. Hyperleptinaemia: the missing link in the metabolic syndrome? Diabet Med. 1997;14:200–8.CrossRefGoogle Scholar
  66. 66.
    Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type II diabetes. A population based study. Am J Respir Crit Care Med. 2005;172:1590–5.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Rebrin K, Steil GM, Mittelman S, et al. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output. J Clin Invest. 1996;98:741–9.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329–39.CrossRefPubMedGoogle Scholar
  69. 69.
    Speigel K, Tasali E, Penev P, et al. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141:846–50.CrossRefGoogle Scholar
  70. 70.
    Cheng N, Cai W, Jiang M, et al. Effect of hypoxia on blood glucose hormones, and insulin receptor functions in newborn calves. Pediatr Res. 1997;41:852–6.CrossRefPubMedGoogle Scholar
  71. 71.
    Raff H, Bruder ED, Jankowski BM. The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine. 1999;11:37–9.CrossRefPubMedGoogle Scholar
  72. 72.
    Larsen JJ, Hansen JM, Olsen NV, et al. The effect of altitude hypoxia on glucose homeostasis in men. J Physiol. 1997;504:241–9.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Braun B, Rock PB, Zamudio S, et al. Women at altitude: short-term exposure to hypoxia and/or α1-adrenergic blockade reduces insulin sensitivity. J Appl Physiol. 2001;91:623–31.PubMedGoogle Scholar
  74. 74.
    Hjalmarsen A, Aasebo U, Birkeland K, et al. Impaired glucose tolerance in patients with chronic hypoxic pulmonary disease. Diabetes Metab. 1996;22:37–42.PubMedGoogle Scholar
  75. 75.
    Tijhonen M, Partinen M, Narvanen S. The severity of obstructive sleep apnoea is associated with insulin resistance. J Sleep Res. 1993;2:56–61.CrossRefGoogle Scholar
  76. 76.
    Veldhuis JD, Iranmanesh A. Physiological regulation of the human growth hormone (GH)-insulin-like growth factor type I (IGF-I) axis: predominant impact of age, obesity, gonadal function, and sleep. Sleep. 1996;19:S221–4.CrossRefPubMedGoogle Scholar
  77. 77.
    Speigel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435–9.CrossRefGoogle Scholar
  78. 78.
    Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.CrossRefPubMedGoogle Scholar
  79. 79.
    Mondini S, Guilleminault C. Abnormal breathing patterns during sleep in diabetes. Ann Neurol. 1985;17:391–5.CrossRefPubMedGoogle Scholar
  80. 80.
    Katsumata K, Okada T, Miyao M, et al. High incidence of sleep apnea syndrome in a male diabetic population. Diabetes Res Clin Pract. 1991;13:45–51.CrossRefPubMedGoogle Scholar
  81. 81.
    Grunstein RR, Ho KY, Sullivan CE. Sleep apnea in acromegaly. Ann Intern Med. 1991;115:527–32.CrossRefPubMedGoogle Scholar
  82. 82.
    Catterall JR, Calverley PM, Ewing DJ, et al. Breathing, sleep, and diabetic autonomic neuropathy. Diabetes. 1984;33:1025–7.CrossRefPubMedGoogle Scholar
  83. 83.
    Kendzerska T, Gershon AS, Hawker G, et al. Obstructive sleep apnea and incident diabetes. A historical cohort study. Am J Respir Crit Care Med. 2014;190:218–25.CrossRefPubMedGoogle Scholar
  84. 84.
    Resnick H, Redline S, Shahar E, et al. Diabetes and sleep disturbances. Findings from the sleep heart health study. Diabetes Care. 2003;26:702–9.CrossRefPubMedGoogle Scholar
  85. 85.
    Stoohs RA, Facchini F, Guilleminault C. Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med. 1996;154:170–4.CrossRefPubMedGoogle Scholar
  86. 86.
    Elmasry A, Janson C, Lindberg E, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med. 2000;248:13–20.CrossRefPubMedGoogle Scholar
  87. 87.
    Al Delaimy WK, Manson JE, Willett WC, et al. Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol. 2002;155:387–93.CrossRefPubMedGoogle Scholar
  88. 88.
    Facchini F, Stoohs R, Harter R, et al. Sleep related glucose and insulin plasma concentrations in obese patients with obstructive sleep apnea before and after treatment with nasal CPAP [Abstract]. J Sleep Res. 1992;1 suppl 1:71.Google Scholar
  89. 89.
    Smurra M, Philip P, Taillard J, et al. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med. 2001;2:207–13.CrossRefPubMedGoogle Scholar
  90. 90.
    Brooks B, Cistulli P, Borkman M, et al. Obstructive sleep apnea in obese on insulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab. 1994;79:1681–5.PubMedGoogle Scholar
  91. 91.
    Harsch IA, Pour Schahin S, Radespiel-Tröger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 2004;169:156–62.CrossRefPubMedGoogle Scholar
  92. 92.
    Harsch IA, Pour Schahin S, Brückner K, et al. The effect of continuous positive airway pressure treatment on insulin sensitivity in patients with obstructive sleep apnoea syndrome and type 2 diabetes. Respiration. 2004;71:252–9.CrossRefPubMedGoogle Scholar
  93. 93.
    Babu AR, Herdegen J, Fogelfeld L, et al. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165:447–52.CrossRefPubMedGoogle Scholar
  94. 94.
    Barceló A, Barbé F, de la Peña M, et al. Insulin resistance and daytime sleepiness in patients with sleep apnoea. Thorax. 2008;63:946–50.CrossRefPubMedGoogle Scholar
  95. 95.
    Coughlin SR, Mawdsley L, Mugarza JA, et al. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J. 2007;29:720–7.CrossRefPubMedGoogle Scholar
  96. 96.
    Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep. 2012;35:617–25B.CrossRefPubMedPubMedCentralGoogle Scholar
  97. 97.
    Yang D, et al. Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath. 2013;17(1):33–8.CrossRefPubMedGoogle Scholar
  98. 98.
    Yang D, Liu Z, Yang H. The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non‐diabetic patients with moderate to severe obstructive sleep apnea. Diabetes Metab Res Rev. 2012;28(6):499–504.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Division of Pulmonary and Critical Care MedicineWinthrop-University HospitalMineolaUSA

Personalised recommendations